文献

Cellartis® DEF-CS™ 500 Culture System

使用文献

  1. iPS細胞を用いた発がん初期過程の解析にてCellartis iPS細胞株、Cellartis DEF-CS 500 Culture System、Cellartis Definitive Endoderm Differentiation Kitを使用
    ROS control in human iPS cells reveals early events in spontaneous carcinogenesis.
    Oka, S., et al., Carcinogenesis (2019).
  2. Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells.
    Karin Säljö2 et al. (2016) Dec；Glycobiology: 10.1093/glycob/cww125.
  3. One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.
    Annika Asplund et al. (2016) Feb；Stem Cell Rev. 12(1):90-104.
  4. Collagen Type I Improves the Differentiation of Human Embryonic Stem Cells towards Definitive Endoderm
    Rasmussen CH. et al. (2015) Dec 29; PLoS One. 10(12):1-21.
  5. MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity
    Kia R et al. (2015) Mar; Toxicol Sci. 144(1):173-185.
  6. β-Catenin Regulates Primitive Streak Induction through Collaborative Interactions with SMAD2/SMAD3 and OCT4
    Funa NS et al. (2015) June 4; Cell Stem Cell 16:1-14.
  7. Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: A first step toward a clinical-grade cell source.
    Boreström, C. et al. (2014) Stem Cells Trans. Med. 3:433-447.
  8. Transplantation of human embryonic stem cells onto a partially wounded human cornea in vitro.
    Hanson, C. et al. (2013) Acta ophthalmologica 91(2):127-130.
  9. Distinct gene expression signatures in human embryonic stem cells differentiated towards definitive endoderm at single-cell level.
    Norrman, K. et al. (2013) Methods 59(1):59-70.
  10. Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor.
    Sivertsson, L. et al. (2012) Stem cells and development 22(4):581-594.
  11. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad, M. et al. (2013) Biochemical pharmacology 86(5):691-702.
  12. Efficient strategies for TALEN-mediated genome editing in mammalian cell lines.
    Valton, J. et al. (2014) Methods 69(2):151-170.
  13. Stem cell responses to plasma surface modified electrospun polyurethane scaffolds.
    Zandén, C. et al. (2014) Nanomedicine: Nanotechnology, Biology and Medicine 10(5):949-958.
  14. Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells.
    Osada N, et al.(2018) Oncotarget. 9, 6450-6462
  15. Borestöm C, et al.,A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell–derived kidney model for drug discovery
    Kidney Int.2018 Jul 20. pii: S0085-2538(18)30356-9. doi: 10.1016/j.kint.2018.05.003.
  16. Development of trophoblast cystic structures from human induced pluripotent stem cells in limited-area cell culture.
    Zhuosi Li, et al.,(2018) Biochem Biophys Res Commun. 505(3):671-676.
  17. Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs.
    Okamoto, Sachiko, et al. Scientific Reports (2019) 9(1):4811.

参考文献

iPS細胞作製関連受託とDEF-CS培地による未分化維持培養
榎　竜嗣、峰野　純一
BIO Clinica　幹細胞と再生医療　VOL.30 No.5 MAY 2015　p76-81
元のページへ